NSF Volume 48, Issue 1 (January 2020): Pediatric brain tumor: evolving treatment strategies

Neurosurgical Focus covers a different topic in-depth each month. Enhanced by color images and video clips, each peer-reviewed issue constitutes a state-of-the-art “textbook chapter” in the field of neurosurgery. 

While Neurosurgical Focus is open-access and has been free to the public since 1996, claiming CME credit is free only for AANS members. Each monthly issue offers 3 credits - earn up to 36 CME annually.

Registration Fee

AANS MembersFree

CME Credit

Earn up to 3 CME credits by participating.

Learning Objectives

Upon completion of this CME activity, participants should be able to:

  1. Discuss pediatric neuro-oncology including both benign and malignant pediatric brain and spine tumors.
  2. Express a greater knowledge of basic, preclinical and clinical paradigms of pediatric neuro-oncology.
  3. Identify molecular stratification of tumors (genomic, expressomic, and epigenetic), targeted therapeutics, clinical trials within the molecular landscape, immune-therapy, precision medicine, molecular diagnostics, liquid biopsy of cerebrospinal fluid and blood, machine learning/artificial intelligence based analysis, impacts of operative management, treatment options in very young patients, congenital tumors, new WHO tumor entities, genetic predisposition syndromes, irradiation therapy, focused ultrasound, convection enhanced delivery, and laser interstitial thermal therapy.
  4. Review the complexities of pediatric neuro-oncology patient management.

Disclosure Information

The AANS controls the content and production of this CME activity and attempt to ensure the presentation of balanced, objective information.  In accordance with the Standards for Commercial Support established by the Accreditation Council for Continuing Medical Education (ACCME), speakers, paper presenters/authors and staff (and the significant others of those mentioned) are asked to disclosed any relationship they or their co-authors have with commercial interests which may be relate to the content of their lecture.

The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for education service elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

It is the policy of the AANS that all individuals in a position to affect the content of a CME activity disclose relationships that they or their spouse/partner have with commercial entities.  Further, should any such relationship be determined to be in possible conflict of interest as it relates to the individual’s proposed role in the CME activity, such conflicts of interest will be resolved prior to confirmation of the individual’s participation.

All potential conflicts of interest have been reviewed by an effective peer review committee to ensure the content is valid and aligned with the interest of the activity audience.

Those who have reported they do not have any relationships with commercial interests:

Todd Hankinson, MD, MBA, FAANS

Michael Karsy, MD, PhD

John Williams, MD


The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

Accreditation Designation

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AANS designates this journal-based CME for a maximum of 3.00 AMA PRA Category 1 CreditTM.

Physicians should claim only credit commensurate with the extent of their participation in the activity.

Term of approval is for three years, beginning from 01/01/2020 to 01/30/2023.

Upon successful completion of the CME test, credit will automatically be reflected in your member record. Non-members must print a certificate and retain a copy for your CME records. 

Copyright © 2020 American Association of Neurological Surgeons


Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care
Select the "Read Article" button to begin.
Select the "Read Article" button to begin. John Williams, MD
Adamantinomatous Craniopharyngioma: Moving Towards Targeted Therapies
Select the "Read Article" button to begin.
Select the "Read Article" button to begin. Todd Hankinson, MD, MBA, FAANS
Liquid biopsies for the diagnosis and surveillance of primary pediatric central nervous system tumors: A review for practicing neurosurgeons
Select the "Read Article" button to begin.
Select the "Read Article" button to begin. Michael Karsy, MD, PhD
10 Questions  |  2 attempts  |  7/10 points to pass
10 Questions  |  2 attempts  |  7/10 points to pass
6 Questions
6 Questions Course Evaluation
CME Certificate
3.00 CME credits  |  Certificate available
3.00 CME credits  |  Certificate available